^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    MAP2K1 F53Y

    i
    Other names: MAP2K1, MAPKK1, MEK1, PRKMK1, Mitogen-activated protein kinase kinase 1
    Entrez ID:
    5604
    Related biomarkers:
    Expression
    Mutation
    CNA
    Others
    over4years
    Dynamic evolution of clonal composition and neoantigen landscape in recurrent metastatic melanoma with a rare combination of driver mutations. (PubMed, J Invest Dermatol)
    The mutant proteins cooperatively activate the MAP kinase signalling pathway confirming they are potential driver mutations of this tumour. We hence describe the long-term genetic evolution of cutaneous metastatic melanoma characterised by an unexpected phenotypic stability and neoantigen driven clonal selection.
    Journal
    |
    BRAF (B-raf proto-oncogene) • NRAS (Neuroblastoma RAS viral oncogene homolog) • MAP2K1 (Mitogen-activated protein kinase kinase 1)
    |
    BRAF mutation • BRAF fusion • MAP2K1 F53Y